Probiotic Supplementation in Children With ADHD
Launched by ST. MARY'S UNIVERSITY, TWICKENHAM · Dec 2, 2021
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Children with Attention Deficit Hyperactivity Disorder (ADHD) can suffer debilitating symptoms, including problematic behaviour and sleep. Dietary manipulations may be a helpful treatment option for children, but the most effective are highly restrictive, with little known about why they might work.
Optimising gut bacteria may help alleviate some of the symptoms of this condition via the gut-brain-axis. The consumption of a probiotic fermented drink (kefir) can positively influence composition of gut bacteria.
The purpose of this study is to explore the effects of supplementation of a pro...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A previous diagnosis of ADHD according to the DSM-IV or DSM-V criteria by a qualified health care professional.
- • Children aged between 8 and 13 years at the time of study.
- • Children with a comorbidity will be accepted.
- • Both males and females
- Exclusion Criteria:
- • Children currently undergoing a current course of behavioural therapy.
- • Children with a reported milk allergy or lactose intolerance.
- • Reported use of antibiotics, probiotics, antifungals or steroids in the past four weeks.
- • Diagnosis of a gastrointestinal disorder e.g., Inflammatory Bowel Disease or Coeliac disease.
- • Diagnosis of an auto-immune disease or compromised immunity.
About St. Mary's University, Twickenham
St. Mary's University, Twickenham, is a distinguished institution dedicated to advancing health and social sciences through innovative research and education. With a strong commitment to ethical practices and community engagement, the university actively sponsors clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging a collaborative approach, St. Mary's University fosters partnerships with healthcare professionals, researchers, and industry stakeholders to ensure rigorous study design and impactful findings. The institution's focus on excellence and integrity positions it as a vital contributor to the evolving landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, Greater London, United Kingdom
Patients applied
Trial Officials
Kate Lawrence, PhD
Principal Investigator
St. Mary's University, Twickenham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials